Catalyst Pharmaceuticals Inc
F:CN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Catalyst Pharmaceuticals Inc
F:CN2
|
US |
|
Acceleware Ltd
XTSX:AXE
|
CA |
|
Bactech Environmental Corp
OTC:BCCEF
|
CA |
|
S
|
South China Vocational Education Group Co Ltd
HKEX:6913
|
CN |
|
A
|
Arinsiri Land PCL
SET:ARIN
|
TH |
|
F
|
Flexopack SA
ATHEX:FLEXO
|
GR |
|
Y
|
YourWay Cannabis Brands Inc
OTC:YOURF
|
CA |
|
F
|
Filtronic PLC
XMUN:FTI
|
UK |
|
E
|
Erotik Abwicklungsgesellschaft AG
F:USE
|
DE |
|
N
|
Neooto Co Ltd
KOSDAQ:212560
|
KR |
|
S
|
Salazar Resources Ltd
XBER:CCG
|
CA |
|
A
|
Amapa Minerals Holdings Inc
TSX:AMAP
|
CA |
|
WTB Financial Corp
OTC:WTBFB
|
US |
|
NR 21 SA
PAR:NR21
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CN2's stock price target?
Not Available
CN2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Revenue over the next 8 years is 7%.
What is the Gross Profit forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 9%.
What is the Net Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 5 years is 26%.
